Nippon Chemiphar Co., Ltd. Reports Consolidated Earnings Results for the Fiscal Year Ended March 31, 2012; Provides Earnings Guidance for the Fiscal Year 2012
May 24, 2012
Share
Nippon Chemiphar Co., Ltd. reported consolidated earnings results for the fiscal year ended March 31, 2012. For the period, the company reported total sales of JPY 28,513 million against JPY 27,361 million a year ago. Operating income was JPY 2,923 million against JPY 1,999 million a year ago. Ordinary income was JPY 2,776 million against JPY 1,818 million a year ago. Net income was JPY 1,439 million or JPY 34.62 EPS against JPY 573 million or JPY 13.95 EPS a year ago. Current debt was JPY 12,871 million against JPY 12,035 million a year ago. Net assets per share were JPY 248.92 against JPY 212.92 a year ago.
For the fiscal year 2012, the company expected total sales of JPY 32,000 million, operating income of JPY 3,500 million, ordinary income of JPY 3,300 and net income of JPY 1,800 or JPY 43.28 EPS.
NIPPON CHEMIPHAR CO., LTD. is a Japan-based company centered on ethical pharmaceutical products and mainly engaged in the pharmaceutical, health and beauty related businesses. The Companyâs Pharmaceutical segment is engaged in the manufacture and sale of ethical pharmaceutical products. Other businesses include entrusted safety testing, healthcare and real estate leasing business. The Company mainly operates in Japan and Vietnam.
Nippon Chemiphar Co., Ltd. Reports Consolidated Earnings Results for the Fiscal Year Ended March 31, 2012; Provides Earnings Guidance for the Fiscal Year 2012